Hypocomplementemia during tocilizumab treatment
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000029528
Abstract: Abstract Hypocomplementemia has been reported in patients with rheumatoid arthritis treated with tocilizumab (TCZ), but its long-term consequences are unknown. We assessed the long-term outcome of patients treated with TCZ who developed hypocomplementemia regarding serious… read more here.
Keywords: hypocomplementemia; tcz treatment; patients treated; tocilizumab ... See more keywords
Tocilizumab-related hypertriglyceridemia is independent of key molecules regulating lipid metabolism.
Sign Up to like & getrecommendations! Published in 2023 at "European journal of clinical investigation"
DOI: 10.1111/eci.14006
Abstract: INTRODUCTION Tocilizumab(TCZ) treatment is associated with dyslipidemia, including a rise in triglycerides through a mechanism poorly understood. Three molecules play key roles in the regulation of triglyceride metabolism: apolipoprotein C-III(ApoC-III), angiopoietin-like protein 4(ANGPLT4), and lipoprotein… read more here.
Keywords: metabolism; tocilizumab; tcz treatment; regulatory molecules ... See more keywords
A Case of Adult-onset Still's Disease During Pregnancy Treated with Tocilizumab.
Sign Up to like & getrecommendations! Published in 2022 at "Internal medicine"
DOI: 10.2169/internalmedicine.8886-21
Abstract: A 28-year-old woman exhibited a spiking fever, arthritis, and liver disfunction when she was 22 weeks pregnant. She was diagnosed with adult-onset Still's disease (AOSD). As her condition was resistant to corticosteroid therapy, tocilizumab (TCZ)… read more here.
Keywords: onset still; tcz treatment; pregnancy; still disease ... See more keywords